Shefali Bijwadia, a second year medical student and researcher in the Skeletal Muscle Plasticity and Regeneration Laboratory (SMPRL), led by Sarah Greising, PhD, associate professor in the School of Kinesiology, publishes an article in Physiological Reports titled “Exploring skeletal muscle tolerance and whole-body metabolic effects of FDA-approved drugs in a volumetric muscle loss model.”
Co-authors of the article include lab members and colleagues Christiana Raymond-Pope, PhD, Alec Basten, MS, Tommy Lillquist, MS, Mason Lentz, Jarrod Call, PhD (University of Georgia), and Greising. The objective of this study was to investigate the tolerance and efficacy of two FDA-approved pharmaceutical modalities to address the pathophysiology of the remaining muscle tissue after injury, with an anti-fibrotic and a combination of myogenic promoters.